Home Archives 2013

Yearly Archives: 2013

Drug Patent Expirations for February 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
IMODIUM MULTI-SYMPTOM RELIEFMcneilloperamide hydrochloride; simethicone5,489,436Feb 6, 2013
IMODIUM A-D EZ CHEWSMcneilloperamide hydrochloride5,489,436Feb 6, 2013
COLESTIDPharmacia And Upjohncolestipol hydrochloride5,490,987Feb 13, 2013
ZOLOFTPfizersertraline hydrochloride5,248,699*PEDFeb 13, 2013
ARRANONSmithkline Beechamnelarabine5,492,897Feb 20, 2013
ARRANONSmithkline Beechamnelarabine5,747,472Feb 20, 2013
ARRANONSmithkline Beechamnelarabine5,821,236Feb 20, 2013
ABRAXANEAbraxis Biosciencepaclitaxel6,753,006Feb 22, 2013
ABRAXANEAbraxis Biosciencepaclitaxel6,096,331Feb 22, 2013
ABRAXANEAbraxis Biosciencepaclitaxel5,439,686Feb 22, 2013
ABRAXANEAbraxis Biosciencepaclitaxel6,749,868Feb 22, 2013
ABRAXANEAbraxis Biosciencepaclitaxel6,537,579Feb 22, 2013
ABRAXANEAbraxis Biosciencepaclitaxel6,506,405Feb 22, 2013
DATSCANGe Hlthcare Incioflupane i-1235,310,912Feb 25, 2013
PREZISTAJanssen Prodsdarunavir ethanolate6,335,460*PEDFeb 25, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.